이 팟캐스트 소개 🔗

업데이트 빈도:
every 50 days
평균 오디오 길이:
23 minutes
게스트 인터뷰
스폰서 있음
영어
미국
에피소드 33 개
2023년 2월 16일부터
episodic

최신 에피소드 🔗

In this episode, we hear from Megan O'Brien, Associate Director at Access Infinity, to explore why understanding payer perception is so difficult to capture in a structured way.  Megan shares how traditional KPIs like time to access and price only tell part of the story, and why the softer, mo…

과거 에피소드 검색

Market Access Matters 의 과거 에피소드를 검색하세요.

이전 에피소드

Most Favored Nation (MFN) pricing has taken over conversations at conferences, client meetings, and boardrooms alike, but what does it actually mean in practice? In this episode, we continue the conversation on evolving US pricing policy. Host Louise Bennett is joined by three of the Access Infinit…
In this episode we sit down with Nikhil Taxak, Head of Pricing and Market Access Data Analytics at Access Infinity, to explore the rapidly evolving market access landscape.From the US Most Favored Nation (MFN) policy and Germany's Medical Research Act to surprising developments in Japan's…
In this episode, we're joined by Louisa Oliver Byrne, Senior Consultant at Access Infinity. We learn about the complexities of the Most Favored Nation (MFN) policy and its implications for pharmaceutical market access. Louisa shares insights from her recent research on MFN, exploring how direc…
In this episode, we invite Access Infinity Partner, Isabel Rubio back to the podcast  to explore the unique challenges and innovative solutions reshaping market access and pricing within rare disease.   Isabel shares insights from her extensive experience with due diligence assessments in orphan dr…
In this insightful episode we speak with Lizzie Shanahan, Global Access AI Strategy Lead at Sanofi. With over six years' experience at Sanofi and a rich background in commercial roles, Lizzie shares her unique journey into the world of market access and how her diverse experience shapes her ap…
In this episode, we speak with Silvy Mardiguian, Senior Director and Head of HEOR for Europe & New Markets at BeiGene.   Silvy has been co-leading BeiGene’s preparedness and organisational readiness for the new Joint Clinical Assessment (JCA) framework, which is going to significantly change th…
In this episode we chat with Jie Shen, who is Vice President Global Head Market Access at CSL. Having started her career in pharma before the market access function existed, Jie is an industry veteran. We cover the changes she's seen over the last 24 years, including multi-stakeholder capitali…
We're kicking off 2025 with a fantastic podcast episode featuring Katrin Jack, Global Access Strategy Head at Galderma and President of the Healthcare Businesswomen's Association Zürich-Zug Chapter.  This episode covers a lot of ground, from the 'sliding doors' moment that led K…
In this episode we speak with Ezgi Erdogan who is Oncology Market Access Director for Emerging Markets at GSK. In this discussion, we cover the unpredictability of emerging markets and the unique challenges this presents. Ezgi also shares her future predictions for access in emerging markets and ta…
면책 조항: 이 페이지에 포함된 팟캐스트와 작품은 Access Infinity 에서 가져온 것입니다. 이 팟캐스트는 소유자의 재산이며 Listen Notes, Inc.와 제휴하거나 보증하지 않습니다.